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COMMENTARY
Let microorganisms do the talking, let us 
talk more about microorganisms
Corrado Nai1,2* , Boris Magrini3 and Julia Offe4
Abstract 
Microorganisms are of uttermost importance, yet in the eyes of the general public they are often associated with dirt 
and diseases. At the same time, microbiologists have access to and comprehensive knowledge of just a tiny minor-
ity of the microbial diversity existing in nature. In this commentary, we present these issues of public misconception 
and scientific limitations and their possible consequences, and propose ways to overcome them. A particular interest 
is directed toward the secondary metabolism of filamentous fungi as well as novel outreach activities, including so-
called “science slams” and interactions between the arts and the sciences, to raise awareness about the relevance of 
microorganisms.
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You’ve got to respect microbes. Not because “they are 
the only culture some people have,” as the comedian 
Steven Wright puts it. Neither are we talking about a 
reverential awe, fuelled by recurrent news of killer bugs 
and pandemic threats. Yes, microbes can be dangerous 
and can spread diseases easily around the globe. We are 
occasionally unable to tame them, as recent outbreaks 
of Ebola or Zika viruses [1, 2] as well as of devastating 
plant pathogens testify [3]. And despite them being 
considered the simplest life form on earth, we still don’t 
know microbes as well as we need to. But in this lies also 
the beauty of them: in many regards, microorganisms are 
nature’s treasure trove awaiting to be opened.
The respect we are referring to is related to a fascina-
tion for microbes. Studies on microorganisms paved the 
way for crucial advances in major pillars of our mod-
ern society as medicine, human welfare [4–8], indus-
try [9–11] and research [12, 13]. Some environmental 
species can break down or assimilate toxic compounds 
or pollutants and are useful in bioremediation [14, 15]. 
Microorganisms like Escherichia coli, Saccharomyces cer-
evisiae and Neurospora crassa have been the workhorses 
of molecular biology and playgrounds for scientific and 
technological breakthroughs [13, 16, 17]; recent discover-
ies on the “immune system” of streptococci [18] are cur-
rently used as CRISPR/Cas technology to edit genomes 
across all domains of life, including human zygotes [19] 
and embryos [20], and fuelling an ongoing scientific 
revolution [21, 22]. And yet, if at the basis of respect lies 
understanding, there are still lacunae to overcome—as 
much for the general public as for biologists or scientists 
themselves.
Microbiologists: the hipsters among scientists
Scientists know and have access to only an estimated 1 % 
of microbial diversity, as predicted by molecular methods 
and metagenomics analyses [23]; the rest is referred to as 
the “microbial dark matter” [24–26]. The main reason is 
the somehow limited palette of methods at microbiolo-
gists’ hand. Since Robert Koch first grew microbial colo-
nies on a potato slice in the late nineteenth century—and 
soon after on gelatinous, homogeneous media in dishes 
named after his assistant Julius Petri  (Fig.  1)—[27] not 
much has really changed. Microbiologists still aim for 
pure cultures of microbes on solid or in liquid media as 
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microbes before it was cool, and do it today (almost) 
exactly alike.
These culture-dependent methods are microbiology’s 
double-edged sword. When they succeed in growing a 
new strain and in studying it in the laboratory, micro-
biologists alienate it from its natural habitat: in nature, 
microbes are highly promiscuous and most likely never 
grow axenically and in homogeneous substrata. To give 
a rough idea, a gram of soil harbours an estimate of 109 
microbial cells and 1000 different species [28, 29]. The 
microbial diversity on us (e.g. the skin) and within our 
body (e.g. the gut) is similarly stunning: microorganisms 
outnumber our own cells (by a factor of up to ten accord-
ing to some estimate [30–32]), so that humans are often 
referred as “superorganisms”. The positive effect of the 
human microbiome for the health of animals and plants 
is increasingly acknowledged, even if still poorly under-
stood [33–35]. Similarly, the microbial community con-
text should no longer be overlooked when investigating 
microbial pathogenesis, a goal that could be achieved by 
revisiting the classical Koch’s postulates [36].
Overcoming microbiologists’ culture‑dependent 
limitations
Several protocols successfully overcome some limita-
tions in microbiological methods. It’s now possible to 
cultivate cells in situ, inoculate them in controlled model 
systems, recreate natural conditions in the lab as well as 
grow mixed cultures instead of axenic ones or directly 
analyse chemical exchanges among microorganisms by 
mass spectrometry [37–43]. Yet during experiments 
with standard and reproducible conditions (a prereq-
uisite for scientific consistency) some kind of complex-
ity is invariably lost, and co-cultivation studies with as 
few as three species are cumbersome and extremely rare 
[42].
Some interactions amongst microorganisms are known 
and well characterised, as for example in intra-species 
communications (e.g. in the processes of quorum sens-
ing [44] or biofilm formation [45, 46]) or in ecologically 
relevant, positive bipartite partnerships like lichens or 
mycorrhiza [47–49]. Other examples of associations 
involving microorganisms are those with marine sponges 
[50] or within the digestive tract of animals [51]. Due to 
the complexity and inaccessibility of those microbiomes 
and habitats, however, the same drawbacks as outlined 
above exist (in particular, cultivation of the microbes and 
establishment of model systems to investigate them in 
the laboratory). For the overwhelming majority of cases, 
therefore, microorganisms cohabitate the same niche 
and/or host, and we don’t have any clue which kind of 
interactions they undergo—like anonymous neighbours 
in a multistory building who occasionally (if at all) greet 
each other on the stairway.
Secondary metabolism with primary significance
Related to this is the fact that, even for well-known 
industrial organisms studied and exploited for decades 
like the filamentous ascomycete Aspergillus niger, there 
is a so-called “secondary metabolism” which is mostly 
inactive under industrially used conditions and axenic 
growth [52–54]. This metabolism is required for “sec-
ondary” roles (e.g. to adapt to stress conditions and the 
presence of competitors [55, 56]), and it is consequently 
silent in the controlled settings of a research laboratory 
or fermentation process. Microbial secondary metabo-
lites with antibiotic, anti-tumoral, psychotropic, cyto-
toxic, anti-cholesterol or immunosuppressant properties 
have been isolated [57, 58]. The interest of the microbial 
secondary metabolism for medicine and biotechnology is 
undisputed.
Cell-to-cell communication among microbes is inves-
tigated as a potent stimulus to activate their silent sec-
ondary metabolism [59–64]. When cells are competing 
with their neighbours for space or resources, they 
secrete secondary metabolites to engage in a chemi-
cal warfare. There seems to be a correlation between 
microbial promiscuity and ability to secrete secondary 
metabolites, as exemplified from the fact that soil micro-
organisms are the primary source of antibiotics [65, 
66]. Nonetheless, microorganisms dwelling in scarcely 
inhabited regions like Antarctica produce antimicrobi-
als as well [67] and these niches should be considered 
as well when hunting for new putative drug-producing 
strains.
Antibiotic resistance is on the rise [68–71] and since the 
last two decades no new class of antimicrobial has been 
Fig. 1 Hipster moustache for hipster microbiologists—here Julius 
Richard Petri (1852–1921), the German bacteriologist eponymous 
with the dishes to cultivate microbes. Technical and methodological 
advances in microbiology have not progressed with the same pace 
as in other fields of the natural sciences (for details, see text; picture 
from https://commons.wikimedia.org)
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developed [72]. The shadow of a “pre-antibiotic” era does 
not belong to a distant past but might return as a consid-
erable threat, and new antimicrobials are urgently sought 
after. Taken together, the need for new antibiotics, com-
pounded by our inability to grow many microorganisms, 
leads the exploitation of microbial secondary metabolism 
in natural niches an important experimental goal.
Filamentous fungi as the workhorses 
of biotechnology
Among microorganisms, filamentous fungi hold great 
promises for biotechnology and medicine. In particular, 
their metabolic and physiological versatility along with 
their intrinsic resistance toward physical and chemical 
stresses makes them unequalled among other biotech-
nologically-relevant microorganisms [73–75]. Recent 
advances in molecular biology, “-omics” techniques and 
synthetic biology allowed a better understanding of the 
molecular cell biology of industrial relevant filamentous 
fungi, as for example members of the genus Aspergillus, 
making them attractive as microbial cell factories [76]. 
Having entered the post-genomic era, new exciting possi-
bilities arise for fungal biology [77, 78]. Such knowledge, 
however, has not been matched by advances in microbio-
logical techniques [27, 79], a reason why the natural way of 
living of microorganisms is still obscure and this nature’s 
treasure trove—microbes themselves as well as the sec-
ondary metabolism of well-known species—is mostly shut.
We argue that new cultivation techniques are necessary 
to activate the silent secondary metabolism of filamentous 
fungi, and, in particular, that co-cultivation experiments 
under natural conditions (in situ setting) are greatly imple-
mentable. One way to do this might be the convergence 
of existing approaches into a single laboratory tool. The 
effects of microbial cross-talk in nature might be better 
exploited by exposing complex microbial communities (e.g. 
more than 10–100 different species, including unidentified 
ones) to environmental conditions, instead of grow axenic 
cultures in nature [38, 39] or co-cultivate two species under 
laboratory settings [59–64]. This could be a kind of a “black-
box” approach with “traceable” and reproducible complex-
ity, in which microbial cross-talk as well as unknown and/
or non-standard inputs putatively act in concert to broadly 
activate microbial secondary metabolism. The platform 
necessary to achieve this goal seems to be currently missing 
and needs to be developed and implemented in a suitable 
laboratory device.
Microbes as threats, scientists as imaginary 
characters
Arguably, the general public gropes around in a differ-
ent kind of darkness than that of microbiologists. As the 
relevance of (inter-species) microbial cross-talk in nature 
is still elusive to microbiologists, so seems the commu-
nication on the importance of microorganisms to be lag-
ging, at least judging from the public perception of them. 
Microbes are widely associated with dirt and diseases 
even though, of all microorganisms, probably just a tiny 
fraction is pathogenic to humans, animals or plants.
These kind of misconceptions might be due to a general 
disaffection of society as a whole from scientific facts. 
Science is complicated and scientific results are occa-
sionally exaggerated, oversimplified or misrepresented 
by media outlets or universities press-releases [80]. But 
take a look at popular culture and you won’t find many 
positive characters representing a realistic scientist 
either. Subjectively, in the public eye scientists are often 
seen as either evil Drs. Frankenstein or nerds (without 
doubting that there might well be even evil nerds among 
scientists). By the words of comedian John Oliver, sci-
ence is “the thing we love and respect so much we only 
allow scientists to be portrayed by the like of Arnold 
Schwarzenegger, Nicolas Cage and Al Pacino” [80]. Nei-
ther is literature scoring better. According to the maxim 
“write what you know,” it could be a task for scientists 
to correct that. It is as if, aside from few exceptions [81], 
established scientists write exclusively memoirs or non-
fiction. In line with this, according to the Royal Society 
in London the best science book ever written is not by 
a scientist but by the industrial chemist Primo Levi [82], 
beating among others Charles Darwin, Richard Dawkins 
and James Watson.
More than purely interesting
So why should scientists care, and in particular microbi-
ologists? It would be too easy to bluntly put it as Richard 
Dawkins (who, quoting a journal editor, said “science is 
interesting and if you don’t agree you can fuck off”) [83] 
and we won’t. If, as Isaac Asimov believed, “the saddest 
aspect of life right now is that science gathers knowledge 
faster than society gathers wisdom,” scientists should feel 
concerned.
More understanding by the general public in the impor-
tance of microorganisms might lead to more acceptance 
and more public funding to microbial research. Inform-
ing the taxpayers on where their money goes and provide 
an understandable account of the outcomes should also 
be on the agenda of researchers. To facilitate this, in our 
opinion the scientific community might consider endeav-
ours to close the gap between science and society as an 
activity advancing science; science outreaches could be 
considered as an additional valuable proxy to calculate 
the impact of researchers.
Misunderstanding about scientific facts can have seri-
ous consequences. Amongst the reasons for the increase 
in antibiotic resistance is the wrong use of these drugs by 
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patients, who for example take them after a common cold 
or interrupt the treatment after first signs of healing and 
unnecessarily select for or favour the survival of resist-
ant cells. Of course, several other factors are involved, 
like the (over-)use of antibiotics in intensive farming [84, 
85]; similarly, pharmaceutical companies are less inter-
ested in the decade-long development of drugs that easily 
lose their effectivity [68–71]. Nonetheless, the distance 
between the general public and science is growing bigger, 
and ways to close this gap are sought after.
Science is entertaining, scientists are not nerds
One of the new science communication formats that 
has become increasingly popular is the so-called science 
slam. In science slams, young scientists explain their 
own research projects in 10-min talks that are easy to 
follow, and afterwards the audience gets to vote a winner 
of the “competition”. The important thing is not primar-
ily the scientific outcome of their work, but to explain 
it in an understandable, concise and entertaining way. 
Science slams take place in cultural centers, theaters 
or clubs, usually in the evening  (Fig.  2). So, the scien-
tists leave their ivory tower and become part of popular 
culture.
The concept, invented and developed in Germany over 
the past 10 years [86], is now an integral part of science 
communication in the country, taking place in virtually 
every university town and regularly attracting a crowd of 
up to 1500 visitors. The format is spreading throughout 
other European countries as well as worldwide. The suc-
cess of science slams is partly due to the fact that it pro-
vides the opportunity for direct communication between 
young scientists and the public. It allows researchers to 
break from the restraints of classic scientific communica-
tion, while the audience experiences their enthusiasm at 
the forefront of scientific discovery.
Many universities and scientific societies have embraced 
the science slam as a way to spread knowledge and con-
nect with the public. During this year’s annual confer-
ence of the German Association of General and Applied 
Microbiology, for example, a specific “microbe slam” has 
been attended by over 1000 microbiologists [87]. Science 
slams and several other science communication events, 
like for example the “Long Night of the Sciences” where 
institutions open their door to the general public, are 
cementing a collective conscience that science, like sports 
or the arts, is an integral part of our culture.
In need of more mixed cultures
Artists can substantially contribute to debates in scien-
tific research. The so-called “microbial art” dates back to 
one of the founding fathers of microbiology, Alexander 
Fleming, who used petri dishes as canvas and pigmented 
cultures as “paint” [88]. Almost a century onward, an 
increasing number of projects involving artists, curators 
and institutions have been developed under the common 
“art & science” label. However, artists working within this 
field are often pressured to fulfil the role of bridging the 
gap between the humanities and the sciences. Undenia-
bly, C. P. Snow’s evaluation on the separation between the 
two cultures has been a recurring reference to emphasize 
the necessity of collaborative approaches between artists 
and scientists [89]. We argue that such collaborative work 
can be achieved in more than one way and can be benefi-
cial to everyone. Artists should feel encouraged to inter-
vene in topical issues by questioning the ethical impacts 
on the society regarding the implementation of new tech-
nologies or by querying the collective understanding of 
scientific concepts and facts.
More specifically, artists have been exploring the possi-
bilities offered by the implementation of biotechnologies. 
For example, the “Hu.M.C.C.” (for Human Molecular Col-
onization Capacity) project by Maja Smrekar (Fig. 3) con-
sists of a yogurt produced with a genetically modified 
microorganism containing the artist’s enzyme [90]. At 
first glance, the work appears as a moral forewarning 
about speculative applications of genetic engineering on 
food production. On the contrary, it is primarily an ironic 
comment on the increasingly obsessive demand for flaw-
less and wholesome food by consumers and the encour-
agement to this demand by manufacturer [90]. During 
the 2016 edition of the Transmediale festival in Berlin, 
artist François-Joseph Lapointe engaged in 1000 hand-
shakes with the visitors, while regularly collecting and 
analysing the microbiota of the palm of his hand to gen-
erate varying “Microbiome Selfies” [91]. His work is not 
so much concerned with questions about lack of knowl-
edge on the occurrence of such organisms on our skin, 
but rather aimed at denouncing the use of antibacterial 
Fig. 2 Science slams represent an effective way to close the gap 
between the scientists and the general audience. The format, which 
attained much popularity in Germany, foresees that young scientists 
present their research in an entertaining, easily understandable way 
(picture by Julia Offe)
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products for everyday care. A group of researchers, art-
ists and hackers have created a platform to engage in 
citizen’s science projects such as public workshops and 
networking events with the purpose to facilitate the 
understanding of scientific research in the field of bio-
technologies, but also to develop open-source and DIY/
DIWO tools [92]. By turning to alternative models of 
knowledge sharing, members of the “Hackteria” collec-
tive refuse to distinguish between artistic production 
and scientific research, affirming the possibility of other 
solutions that are not heavily dependent from financial 
support, and consequently from the endorsement of 
funding agencies and commercial partners, from which 
both the scientific and the artistic fields strongly depend. 
The power of synthetic biology is uncovered by the work 
of Alexandra Daisy Ginsberg “Designing for the Sixth 
Extinction” [93]. In her science-fiction-oriented scenar-
ios, synthetic species counterintuitively provide a tool for 
bioremediation and preservation of biological diversity. 
Here, scientific concepts and artistic creativity merge for 
a shared endeavour [74].
Artists should not simply act as translators of scientific 
ideas: they can shape them as well as the directions of 
the scientific research into areas that are more relevant 
and urgent for our society. With the words of the recently 
departed chemistry Nobel Prize laureate and graphic art-
ist Harry Kroto: “In science, the universe is in control; in 
art, you are” [94]. The perspective is in either case both 
scaring and fascinating, the outcomes—much in good 
science as in good art—unpredictable and enlightening.
A last word
It is essential that society engages in the debate on the 
importance of science in general, and in particular on 
those of microorganisms and their biotechnological 
potential. However, to counteract the antibiotic crisis, 
and to inform about the urgent necessity of this, is not 
an easy task. We believe that insights about communica-
tion among microorganisms—gained by microbiologists 
with appropriate new tools and approaches—as well as 
on microorganisms—by the concerted action of scien-
tists, communicators, artists, scientific institutes and the 
general public—are acutely needed.
As the chemist, entrepreneur and pioneer in microbiol-
ogy and immunology Louis Pasteur is often quoted with: 
“Messieurs, c’est les microbes qui auront le dernier mot!” 
Fig. 3 Views of the “Hu.M.C.C.” (for Human Molecular Colonization Capacity) project by Maja Smrekar at the exhibition “The Hydra Project” at Corner 
College, Zurich (Switzerland) in 2015. Interactions between science and the arts can contribute to the advancement of science and steer it into 
directions relevant for our modern society (pictures by Boris Magrini)
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(“Gentlemen, it’s the microbes who will have the last 
word!”). If we uncover microbial interactions and com-
munication to the fullest, and talk more about microor-
ganisms, there are good chances it is going to be a nice 
word.
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